SOCS3 Gene Polymorphism and Hypertension Susceptibility in Chinese Population: A Two-Center Case-Control Study

Dabin Kuang1, Lichen Dong1, Lingyun Liu2

  • 1The Affiliated Changsha Hospital of Hunan Normal University, Changsha, Hunan 410006, China.

Insights

The Suppressor of Cytokine Signaling 3 (SOCS3) gene variant rs8064821 is linked to a higher risk of hypertension in the Chinese population. This genetic variation may influence hypertension risk by altering SOCS3 gene expression.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • Endothelial inflammation and vascular damage are key risk factors for hypertension.
  • Suppressor of Cytokine Signaling 3 (SOCS3) plays a crucial role in regulating inflammatory pathways.
  • Previous research highlights SOCS3's anti-inflammatory effects in conditions like hypertension and obesity.

Purpose of the Study:

  • To investigate the association between a specific SOCS3 tagSNP (rs8064821) and hypertension risk in the Chinese population.
  • To explore the potential role of SOCS3 gene expression in hypertension development.

Main Methods:

  • A case-control study involving 532 hypertension patients and 569 healthy controls from central China.
  • Genotyping of the SOCS3 rs8064821 C>A polymorphism using the TaqMan assay.
  • Analysis of SOCS3 mRNA levels in peripheral blood mononuclear cells (PBMCs) from healthy donors.

Main Results:

  • The SOCS3 rs8064821 CA genotype was significantly associated with an increased risk of hypertension (OR = 1.821, P = 0.001).
  • The rs8064821 A allele was correlated with higher SOCS3 mRNA expression in PBMCs of healthy individuals.
  • These findings suggest a link between the SOCS3 C>A polymorphism and altered SOCS3 expression.

Conclusions:

  • The SOCS3 rs8064821 C>A polymorphism may contribute to hypertension susceptibility in the Chinese population.
  • The mechanism may involve the regulation of SOCS3 gene expression by this specific polymorphism.
  • This study provides genetic insights into the inflammatory pathways involved in hypertension.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
77
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
148
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
147
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K